New registry tracks MenQuadfi vaccine safety in pregnancy
NCT ID NCT04843111
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 28 times
Summary
This study is a safety registry that tracks pregnant women in the US who received the MenQuadfi vaccine during pregnancy or within 30 days before their last period. Researchers will monitor the health of the mothers and their babies for any side effects or complications. The goal is to gather information on the vaccine's safety in this group, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pennsylvania Locations
RECRUITINGSwiftwater, Pennsylvania, 18370-0187, United States
Conditions
Explore the condition pages connected to this study.